TrianglePUBLICATIONS · 15897554
Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2005 May 15
- First author
- Kaminskas E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kaminskas E
- type
- Author
- name
- Farrell A
- type
- Author
- name
- Abraham S
- type
- Author
- name
- Baird A
- type
- Author
- name
- Hsieh LS
- type
- Author
- name
- Lee SL
- type
- Author
- name
- Leighton JK
- type
- Author
- name
- Patel H
- type
- Author
- name
- Rahman A
- type
- Author
- name
- Sridhara R
- type
- Author
- name
- Wang YC
- type
- Author
- name
- Pazdur R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kaminskas E
- type
- Author
- name
- Farrell A
- type
- Author
- name
- Abraham S
- type
- Author
- name
- Baird A
- type
- Author
- name
- Hsieh LS
- type
- Author
- name
- Lee SL
- type
- Author
- name
- Leighton JK
- type
- Author
- name
- Patel H
- type
- Author
- name
- Rahman A
- type
- Author
- name
- Sridhara R
- type
- Author
- name
- Wang YC
- type
- Author
- name
- Pazdur R
- type
- Author
- bibliography ids
- nci-bib-c082b826920c25ab5d7bf635
- book metadata
- content sha256
- b3d65a07ab01d2edcf8af4aed0306297afde8e6e24b71e085653ca18140a50b9
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-04-2135
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15897554
- immutable id
- pubmed:15897554@b3d65a07ab01d2edcf8af4aed0306297afde8e6e24b71e085653ca18140a50b9
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- Source null
- issn print
- 1078-0432
- issue
- 10
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 3604-8
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15897554
- provenance
- batch id
- c1587c4840dc976b65de
- provider
- NCBI PubMed ESummary
- record sha256
- 3f7945b542ae76090836bbdd49b8477814c999f88a045a4bbaba00f6c028b194
- response sha256
- 1dc03bdea4f6d08d05f92b6e458fb2ffa8a3c523f1f3e268fece6307fc70dead
- retrieved at
- 2026-09-09T23:45:59.852120+00:00
- publication date
- display
- 2005 May 15
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.
Preserved source evidence · Not medical advice